Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats

Neuroscience Letters

Volumn 482, Issue 3, 2010, Pages 255-259

  Azizi, Hossein ^a   Mirnajafi Zadeh, Javad ^a   Rohampour, Kambiz ^a   Semnanian, Saeed ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Locus coeruleus; Morphine withdrawal; Naloxone; Orexin; Orexin type 1 receptor

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; MORPHINE SULFATE; NALOXONE; OREXIN 1 RECEPTOR; POLY(METHYL METHACRYLATE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUXISM; CONTROLLED STUDY; DIARRHEA; LOCUS CERULEUS; MALE; MASTICATION; MICROINJECTION; MORPHINE ADDICTION; NONHUMAN; PRIORITY JOURNAL; PTOSIS; RAT; RECEPTOR BLOCKING; SCRATCHING; WET DOG SHAKES; WISTAR RAT; WITHDRAWAL SYNDROME;

ANIMALS; BENZOXAZOLES; INJECTIONS, INTRAVENTRICULAR; LOCUS COERULEUS; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NARCOTICS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SUBSTANCE WITHDRAWAL SYNDROME; UREA;

EID: 77955920536     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.050     Document Type: Article

References (46)

1. Aghajanian G.K. Central noradrenergic neurons: a locus for the functional interplay between alpha-2 adrenoceptors and opiate receptors. J. Clin. Psychiatry 1982, 43:20-24.
2. Aghajanian G.K., Alreja M., Nestler E.J., Kogan J.H. Dual mechanisms of opiate dependence in the locus coeruleus. Clin. Neuropharmacol. 1992, 15:143A-144A.
3. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 1994, 636:126-130.
4. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 1991, 11:3830-3839.
5. Andrade A., Vandermaelen C.P., Aghajanian G.K. Morphine tolerance and dependence in the locus coeruleus: single cell studies in brain slices. Eur. J. Pharmacol. 1983, 91:161-169.
6. Arihara Z., Takahashi K., Murakami O., Totsune K., Sone M., Satoh F., Ito S., Hayashi Y., Sasano H., Mouri T. Orexin-A in the human brain and tumor tissues of ganglioneuroblastoma and neuroblastoma. Peptides 2000, 21:565-570.
7. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
8. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 1987, 32:633-638.
9. Corrigall W.A. Heroin self-administration: effects of antagonist treatment in lateral hypothalamus. Pharmacol. Biochem. Behav. 1987, 27:693-700.
10. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van Den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:322-327.
11. Doane D.F., Lawson M.A., Meade J.R., Kotz C.M., Beverly J.L. Orexin-induced feeding requires NMDA receptor activation in the perifornical region of the lateral hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R1022-R1026.
12. Fan G.H., Wang L.Z., Qiu H.C., Ma L., Pei G. Inhibition of calcium/calmodulin-dependent protein kinase II in rat hippocampus attenuates morphine tolerance and dependence. Mol. Pharmacol. 1999, 56:39-45.
13. Feng Y.Z., Zhang T., Rockhold R.W., Ho I.K. Increased locus coeruleus glutamate levels are associated with naloxone-precipitated withdrawal from butorphanol in the rat. Neurochem. Res. 1995, 20:745-751.
14. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., Yanagisawa M., Nestler E.J., DiLeone R.J. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 2003, 23(8):3106-3111.
15. Gompf H.S., Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res. 2008, 1224:43-52.
16. Grant S.J., Huang Y.H., Redmond D.E. Behavior of monkeys during opiate withdrawal and locus coeruleus stimulation. Pharmacol. Biochem. Behav. 1988, 30:13-19.
17. Greco M., Shiromani P. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res. Mol. Brain Res. 2001, 88:176-182.
18. Harris G.C., Wimmer M., Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 2005, 437:556-559.
19. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience 2001, 103:777-797.
20. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., van den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 1999, 415:145-159.
21. Hoshi K., Ma T., Ho I.K. Precipitated kappa-opioid receptor agonist withdrawal increase glutamate in rat locus coeruleus. Eur. J. Pharmacol. 1996, 314:301-306.
22. John J., Wu M.F., Kodama T., Siegel J.M. Intravenously administered hypocretin-1 alters brain amino acid release: an in vivo microdialysis study in rats. J. Physiol. 2003, 548:557-562.
23. Kodama T., Kimura M. Arousal effects of orexin-A correlate with GLU release from the locus coeruleus in rats. Peptides 2002, 23:1673-1681.
24. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron 1998, 21:467-476.
25. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 1992, 261:669-677.
26. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 1993, 605:128-138.
27. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2005, Elsevier, Academic Press. 5th ed.
28. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J. Neurosci. 1998, 18:9996-10015.
29. Punch L.J., Self D.W., Nestler E.J., Taylor J.R. Opposite modulation of opiate withdrawal behaviors on microinfusion of a protein kinase A inhibitor versus activator into the locus coeruleus or periaqueductal gray. J. Neurosci. 1997, 17:8520-8527.
30. Rasmussen K., Aghajanian G.K. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res. 1989, 505:346-350.
31. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 1990, 10:2308-2317.
32. Redmond D.E., Huang Y.H., Snyder D.R., Maas J.W. Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res. 1976, 116:502-510.
33. Redmond D.E., Huang Y.H. The primate locus coeruleus and effects of clonidine on opiate withdrawal. J. Clin. Psychiatry 1982, 43:25-29.
34. Rockhold R.W., Liu N.S., Coleman D., Commiskey S., Shook J., Ho I.K. The nucleus paragigantocellularis and opioid withdrawal-like behavior. J. Biomed. Sci. 2000, 7:270-276.
35. Rosin D.L., Weston M.C., Sevigny C.P., Stornetta R.L., Guyenet P.G. Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2. J. Comp. Neurol. 2003, 465:593-603.
36. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
37. Sharf R., Sarhan M., DiLeone R.J. Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell. Biol. Psychiatry 2008, 64:175-183.
38. Soffin E.M., Evans M.L., Gill C.H., Harries M.H., Benham C.D., Davies C.H. SB-334867-A antagonises orexin mediated excitation in the locus coeruleus. Neuropharmacology 2002, 42:127-133.
39. Taylor J.R., Punch L.J., Elsworth J.D. A comparison of the effects of clonidine and CNQX infusion into the locus coeruleus and the amygdala on naloxone-precipitated opiate withdrawal in the rat. Psychopharmacology 1998, 138:133-142.
40. Tokuyama S., Wakabayashi H., Ho I.K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 1996, 295:123-129.
41. Tokuyama S., Zhu H., Wakabayashi H., Feng Y.Z., Ho I.K. The role of glutamate in the locus coeruleus during opioid withdrawal and effects of H-7, a protein kinase inhibitor, on the action of glutamate in rats. J. Biomed. Sci. 1998, 5:45-53.
42. Tose R., Kushikata T., Yoshida H., Kudo M., Furukawa K., Ueno S., Hirota K. Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat. Brain Res. 2009, 1250:81-87.
43. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J. Neurosci. 1998, 18:7962-7971.
44. van der Kooy D., Mucha R.F., O'Shaughnessy M., Bucenieks P. Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference. Brain Res. 1982, 243:107-117.
45. Zhang T., Feng Y., Rockhold R.W., Ho I.K. Naloxone-precipitated morphine withdrawal increases pontine glutamate levels in the rat. Life Sci. 1994, 55:PL25-PL31.
46. Zhou Y., Bendor J., Hofmann L., Randesi M., Ho A., Kreek M.J. Mu opioid receptor and orexin/hypocretin mRNA levels in the lateral hypothalamus and striatum are enhanced by morphine withdrawal. J. Endocrinol. 2006, 191:137-145.